Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JAMES L KIRKLAND

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1487682308
CMS profile
1117290
Location
LOS ANGELES, CA

General Payments · PY2019–2024

$29,940.88

  • Reported across 21 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$13,165.95

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $11,050.00 1
Travel and Lodging $1,615.55 6
Food and Beverage $500.40 9

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $13,165.95 16

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $15,110.63 3
PY2020 $664.30 1
PY2021 $1,000.00 1
PY2024 $13,165.95 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201920202021 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
GlaxoSmithKline, LLC. $103.20 05/21/2024 Food and Beverage Undisputed 01/23/2026 1116135503 CMS
GlaxoSmithKline, LLC. $184.42 05/21/2024 Travel and Lodging Undisputed 01/23/2026 1116714835 CMS
GlaxoSmithKline, LLC. $410.65 05/22/2024 Travel and Lodging Undisputed 01/23/2026 1115821495 CMS
GlaxoSmithKline, LLC. $18.29 05/22/2024 Food and Beverage Undisputed 01/23/2026 1116069456 CMS
GlaxoSmithKline, LLC. $90.24 05/22/2024 Food and Beverage Undisputed 01/23/2026 1116188743 CMS
GlaxoSmithKline, LLC. $22.99 05/22/2024 Food and Beverage Undisputed 01/23/2026 1116252683 CMS
GlaxoSmithKline, LLC. $82.93 05/22/2024 Food and Beverage Undisputed 01/23/2026 1116267498 CMS
GlaxoSmithKline, LLC. $106.96 05/22/2024 Food and Beverage Undisputed 01/23/2026 1116320858 CMS
GlaxoSmithKline, LLC. $22.19 05/22/2024 Food and Beverage Undisputed 01/23/2026 1116360086 CMS
GlaxoSmithKline, LLC. $184.42 05/22/2024 Travel and Lodging Undisputed 01/23/2026 1116533328 CMS
GlaxoSmithKline, LLC. $18.29 05/22/2024 Food and Beverage Undisputed 01/23/2026 1116631822 CMS
GlaxoSmithKline, LLC. $382.30 05/22/2024 Travel and Lodging Undisputed 01/23/2026 1116655601 CMS
GlaxoSmithKline, LLC. $178.35 05/23/2024 Travel and Lodging Undisputed 01/23/2026 1115887656 CMS
GlaxoSmithKline, LLC. $35.31 05/23/2024 Food and Beverage Undisputed 01/23/2026 1116422935 CMS
GlaxoSmithKline, LLC. $275.41 05/23/2024 Travel and Lodging Undisputed 01/23/2026 1116587587 CMS
GlaxoSmithKline, LLC. $11,050.00 09/23/2024 Consulting Fee Undisputed 01/23/2026 1116735086 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2019, 2020, 2021, 2024
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.